Location History:
- Daejon, KR (2011)
- Daejeon, KR (2011 - 2014)
Company Filing History:
Years Active: 2011-2014
Title: Mi Kyung Ji: Innovator in Pharmaceutical Chemistry
Introduction
Mi Kyung Ji is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel piperazine compounds. With a total of 3 patents to his name, Ji's work focuses on innovative solutions for mental health treatment.
Latest Patents
One of Mi Kyung Ji's latest patents involves phenyl piperazine compounds and their pharmaceutical compositions. This invention relates to novel piperazine derivatives or pharmaceutically acceptable salts, which exhibit high binding affinity for the Serotonin 1A (5-hydroxytryptamine; 5-HT1A) receptor. The pharmaceutical composition developed by Ji is aimed at the treatment and prevention of depression and anxiety. It includes an effective amount of the piperazine compound and outlines a method for treating conditions related to the 5-HT1A receptor in mammals.
Career Highlights
Throughout his career, Mi Kyung Ji has worked with prominent companies in the pharmaceutical industry, including SK Holdings Co., Ltd. and SK Biopharmaceuticals Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Mi Kyung Ji has collaborated with several professionals in his field, including Yonggil Kim and Nahmryune Cho. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Mi Kyung Ji stands out as an influential inventor in the realm of pharmaceutical chemistry. His innovative work on piperazine compounds has the potential to significantly impact the treatment of mental health disorders.